Clinical trial
The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients
NCT04329481 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 12, 2018
- Completion date
- June 12, 2024
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn disease, inflammatory bowel diseases, ulcerative colitis